Interestingly, both RUNX1 and RUNX2 are important regulators of early thymopoiesis during the double-negative stages of T lymphocytes [81,82,83,84], a developmental step that has been mapped to the initial oncologic transformation of T cells in MF [10,11,12,13,14,15]. The gene discussed is RUNX2; the disease is mycosis fungoides.